Dr. Thomas Schall | Chairman, President and Chief Executive Officer |
Tausif Butt | Executive Vice President, Chief Operating Officer |
Susan Kanaya | Executive Vice President, Chief Financial and Administrative Officer |
Bill Slattery, Jr. | Vice President of Investor Relations & Corporate Communications |
Joseph P. Schwartz | SVB Leerink |
Ryan Deschner | Raymond James |
Yanan Zhu | Wells Fargo Securities |
Dae Gon Ha | Stifel Nicolaus |
Anupam Rama | J.P. Morgan |
Michelle Gilson | Canaccord Genuity Group Inc. |
Edward White | H.C. Wainwright |
Good afternoon and welcome to the ChemoCentryx First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conclude -- we would conduct a question and answer session.
As a reminder, this conference call will be recorded. I would now like to turn the call over to Mr.